PRQR — ProQR Therapeutics BV

Founder-Led

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates PRQR Bullish with a Setup Score of 9, net conviction 25, actionability 3. How the Setup Score works →

Total Setup Score9
Directional BiasBullish
Net Conviction25
Actionability3 (in range)

Key signals behind this score

About ProQR Therapeutics BV

ProQR Therapeutics N.V., a clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company develops an RNA editing platform through its Axiomer RNA editing technology for genetic disorders with unmet needs. Its lead product candidate, AX-0810, targets na-taurocholate cotransporting polypeptide (NTCP) for the treatment of cholestatic diseases. Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$2.38
Market Cap$320M
Float71.3M
Shares Outstanding141.1M
Price/Sales (TTM)17.39
vs. Analyst Target+245.5% to analyst PT
Profit Margin-228.18%
Operating Margin (TTM)-100.72%
Revenue (TTM)$18.4M
Dividend RateNone
Analyst Target Price$8.22 (8 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $1.0M -$46.6M $1.0M -$48.4M
2021 $1.3M -$60.7M $1.3M -$54.9M
2022 $3.6M -$64.4M $3.6M -$56.5M
2023 $6.5M -$28.1M $6.5M -$24.1M
2024 $18.9M -$27.8M $18.9M -$24.1M
2025 $15.3M -$40.5M $12.7M -$37.0M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Sep 2025 $2.9M -$11.0M
Dec 2025 $4.6M -$8.8M
Mar 2026 $2.1M -$13.6M
Jun 2026 $8.9M -$8.9M

Ownership & Float

Insider Ownership17.2%
Institutional Ownership54.5%
Short Float3.1%
% of All Funds Holding0.80%
Number of Funds Holding70

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$1.87Near-term / short-term trend
Weekly40-Week SMA$1.77Medium-term trend
Weekly80-Week SMA$1.90Cyclical trend (business cycle)
Weekly200-Week SMA$2.04Secular trend (multi-year)
Monthly10-Month SMA$1.83Near-term monthly trend
Monthly20-Month SMA$1.93Medium-term monthly trend
Monthly40-Month SMA$1.97Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$1.80 support 1.23x 0 months ago
$3.80 resistance 1.04x 19 months ago

Historical Earnings Reactions (48 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.42% 0.24% 56.25% 8.15% -3.62%
1 Day -0.52% 0.14% 50.00% 13.66% -21.03%
1 Week 2.40% 1.84% 60.42% 26.49% -12.43%
2 Weeks 3.59% 1.40% 55.32% 49.39% -23.59%
1 Month 10.90% 0.90% 51.06% 189.93% -31.61%

Next earnings: November 1, 2026 (66 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan-14.5%16.7%12
Feb-8.6%41.7%12
Mar-0.1%58.3%12
Apr-2.1%33.3%12
May2.3%50.0%12
Jun4.5%58.3%12
Jul-3.2%41.7%12
Aug8.5%81.8%11
Sep7.1%27.3%11
Oct4.0%33.3%12
Nov4.1%58.3%12
Dec20.1%58.3%12

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.24% 42.1% 563
Tuesday -0.15% 44.5% 618
Wednesday 0.35% 44.4% 615
Thursday 0.34% 44.7% 602
Friday 0.19% 47.8% 601

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 54.5%

Insider Transactions — Smart Summary

Total insider ownership: 17.2%

Founder-led management: Daniel A. de Boer (Founder, Chief Executive Officer and Member of Management Board), Gerard Platenburg (Co-Founder, Chief Scientific Officer and Member of Management Board)

12-Month Insider Activity Summary

Total Filings5
Net Value+$853,460
Net Shares Change800,000
% of Float1.1%
C-Suite Filings3
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
de Boer Daniel Anton Chief Executive Officer +$853,460 3 3 buy
Filius Bart +$488,925 2 2 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-08-03 de Boer Daniel Anton Chief Executive Officer +$353,960 Transaction at $1.77, now +34.5%
2026-07-13 de Boer Daniel Anton Chief Executive Officer +$261,000 Transaction at $1.74, now +36.8%
2026-07-08 de Boer Daniel Anton Chief Executive Officer +$238,500 Transaction at $1.59, now +49.7%
2026-07-21 Filius Bart +$257,925 Transaction at $1.72, now +38.4%
2026-06-30 Filius Bart +$231,000 Transaction at $1.54, now +54.5%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for ProQR Therapeutics BV (PRQR) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for PRQR on Trend Edge →